HomeGeneticsConditionBernard-Soulier syndrome
Back to Condition
Bernard-Soulier syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Bernard-Soulier syndrome

Bernard-Soulier syndrome is a rare bleeding disorder characterized by abnormally large and fewer platelets, leading to easy bruising, nosebleeds, and excessive bleeding.

Overview

Bernard-Soulier syndrome is a bleeding disorder associated with abnormal platelets, which are blood cells involved in blood clotting. In affected individuals, platelets are unusually large and fewer in number than usual (a combination known as macrothrombocytopenia). People with Bernard-Soulier syndrome tend to bruise easily and have an increased risk of nosebleeds (epistaxis). They may also experience abnormally heavy or prolonged bleeding following minor injury or surgery or even without trauma (spontaneous bleeding). Rarely, bleeding under the skin causes tiny red or purple spots on the skin called petechiae. Women with Bernard-Soulier syndrome often have heavy or prolonged menstrual bleeding (menorrhagia).

Frequency

Bernard-Soulier syndrome is estimated to occur in 1 in 1 million individuals; however, some doctors think the condition is underdiagnosed and may be more common.

Causes & Risk Factors

Bernard-Soulier syndrome is caused by mutations in one of three genes: GP1BA, GP1BB, or GP9. The proteins produced from these genes are pieces (subunits) of a protein complex called glycoprotein (GP)Ib-IX-V. This complex is found on the surface of platelets and plays an important role in blood clotting.

The GPIb-IX-V complex can attach (bind) to a protein called von Willebrand factor, fitting together like a lock and its key. Von Willebrand factor is found on the inside surface of blood vessels, particularly when there is an injury. Binding of the GPIb-IX-V complex to von Willebrand factor allows platelets to stick to the blood vessel wall at the site of the injury. These platelets form clots, plugging holes in the blood vessels to help stop bleeding.

Most mutations in GP1BA, GP1BB, or GP9 prevent the formation of the GPIb-IX-V complex on the surface of platelets. Other mutations impair the complex's interaction with von Willebrand factor. All of these mutations impair clot formation, which leads to the excessive bleeding characteristic of Bernard-Soulier syndrome.

Inheritance Pattern

Most cases of Bernard-Soulier syndrome are inherited in an autosomal recessive pattern, which means both copies of the GP1BA, GP1BB, or GP9 gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene. Although most people with only one copy of the mutated gene do not show signs and symptoms of the condition, some have platelets that are slightly larger than normal or very mild bleeding abnormalities.

Rare cases of Bernard-Soulier syndrome caused by mutations in the GP1BA or GP1BB gene are inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. These individuals inherit the condition from an affected parent.

Other Names

  • BDPLT1
  • Bleeding disorder, platelet-type, 1
  • BSS
  • Deficiency of platelet glycoprotein 1b
  • Giant platelet syndrome
  • Glycoprotein Ib, platelet, deficiency of
  • Hemorrhagioparous thrombocytic dystrophy
  • Macrothrombocytopenia, familial Bernard-Soulier type
  • Platelet glycoprotein Ib deficiency
  • Von Willebrand factor receptor deficiency

Frequently Asked Questions

Bernard-Soulier syndrome is inherited in an autosomal recessive pattern. This means both parents must carry a copy of the mutated gene (GP1BA, GP1BB, or GP9) and pass it on for their child to be affected. If both parents are carriers, there is a 25% chance with each pregnancy that their child will have the syndrome, a 50% chance the child will be a carrier, and a 25% chance the child will neither have the syndrome nor be a carrier. Genetic counseling is highly recommended for affected individuals and their families.
Before any surgical or dental procedure, it is crucial to inform all healthcare providers about Bernard-Soulier syndrome. A hematologist should be consulted to develop a bleeding management plan. This plan may include administering platelet transfusions, desmopressin (DDAVP), or antifibrinolytic agents (like tranexamic acid) to reduce the risk of excessive bleeding during and after the procedure.
While easy bruising and nosebleeds are common, severe bleeding can be life-threatening. Seek immediate medical attention for unusually heavy or prolonged bleeding that doesn't stop with pressure, bleeding into joints or muscles causing pain and swelling, severe headaches or changes in consciousness (which could indicate brain bleeding), or significant blood loss from any site, especially after injury or surgery.
Daily management involves avoiding activities that carry a high risk of injury, especially head trauma. It's important to avoid medications that interfere with platelet function, such as aspirin and NSAIDs (e.g., ibuprofen, naproxen), unless specifically advised by a hematologist. Good dental hygiene can help prevent gum bleeding. Always inform healthcare providers about your condition before any medical or dental procedures.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab